The IGF2BP1 expression was significantly upregulated in patients with BC at T3/T4 stage compared with those at the T1/T2 stage (P < 0.001, Fig. 8D), and its level was much higher in ductal invasive tissues (P < 0.001; Fig. 8E). The gene discussed is IGF2BP1; the disease is breast cancer.